Guardant Health, Inc. (GH) stock
GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$151.70−3.16 (-2.04%)
Close on Nov 13, 2026Market cap $20.36BP/E –Yield –
Guardant Health cash
Cash and short-term investments held at the end of each period.
Guardant Health's cash was $1.03B at Sep 30, 2026. For fiscal 2025 it was $1.20B, up 27.3% from the year before. The highest annual figure on record is $1.79B in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20B | +27.3% |
| FY2024 | Dec 31, 2024 | $944.19M | -19.2% |
| FY2023 | Dec 31, 2023 | $1.17B | +15.5% |
| FY2022 | Dec 31, 2022 | $1.01B | +8.4% |
| FY2021 | Dec 31, 2021 | $932.83M | -48.0% |
| FY2020 | Dec 31, 2020 | $1.79B | +243.3% |
| FY2019 | Dec 31, 2019 | $522.80M | +24.8% |
| FY2018 | Dec 31, 2018 | $418.96M | +89.0% |
| FY2017 | Dec 31, 2017 | $221.64M | +559.8% |
| FY2016 | Dec 31, 2016 | $33.59M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.03B | +77.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.05B | +67.4% |
| Q1 FY2026 | Mar 31, 2026 | $1.10B | +57.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.20B | +27.3% |
| Q3 FY2025 | Sep 30, 2025 | $580.01M | -35.2% |
| Q2 FY2025 | Jun 30, 2025 | $629.14M | -32.6% |
| Q1 FY2025 | Mar 31, 2025 | $698.57M | -32.1% |
| Q4 FY2024 | Dec 31, 2024 | $944.19M | -19.2% |
| Q3 FY2024 | Sep 30, 2024 | $895.72M | -22.4% |
| Q2 FY2024 | Jun 30, 2024 | $933.69M | -23.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.03B | +9.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.17B | +15.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.15B | +20.5% |
| Q2 FY2023 | Jun 30, 2023 | $1.22B | +43.5% |
| Q1 FY2023 | Mar 31, 2023 | $937.02M | -2.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.01B | +8.4% |
| Q3 FY2022 | Sep 30, 2022 | $958.04M | -35.5% |
| Q2 FY2022 | Jun 30, 2022 | $853.69M | -52.4% |
| Q1 FY2022 | Mar 31, 2022 | $962.27M | -50.4% |
| Q4 FY2021 | Dec 31, 2021 | $932.83M | -48.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.49B | +46.6% |
| Q2 FY2021 | Jun 30, 2021 | $1.79B | +91.0% |
| Q1 FY2021 | Mar 31, 2021 | $1.94B | +273.1% |
| Q4 FY2020 | Dec 31, 2020 | $1.79B | +243.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.01B | +93.8% |
| Q2 FY2020 | Jun 30, 2020 | $937.83M | +71.9% |
| Q1 FY2020 | Mar 31, 2020 | $520.09M | +11.4% |
| Q4 FY2019 | Dec 31, 2019 | $522.80M | +24.8% |
| Q3 FY2019 | Sep 30, 2019 | $522.96M | +92.4% |
| Q2 FY2019 | Jun 30, 2019 | $545.63M | +390.7% |
| Q1 FY2019 | Mar 31, 2019 | $466.86M | +516.1% |
| Q4 FY2018 | Dec 31, 2018 | $418.96M | +89.0% |
| Q3 FY2018 | Sep 30, 2018 | $271.76M | +45.8% |
| Q2 FY2018 | Jun 30, 2018 | $111.19M | +231.0% |
| Q1 FY2018 | Mar 31, 2018 | $75.77M | – |
| Q4 FY2017 | Dec 31, 2017 | $221.64M | – |
| Q3 FY2017 | Sep 30, 2017 | $186.37M | – |
| Q4 FY2016 | Dec 31, 2016 | $33.59M | – |
See a number that looks wrong?